It’s still 2024, but at BIOVECTRA, we’re already looking ahead to an exciting 2025! First up: the JP Morgan Healthcare Conference in San Francisco. Our team will be in the Bay Area and ready to discuss how we can support your upcoming projects. Schedule time with us to explore our expertise in: - Biologics: Available capacity in our microbial fermentation suites - pDNA, mRNA, and LNP manufacturing - Synthetic small molecules and peptides - Bioreagents - Highly potent APIs: Including payloads and linkers for ADCs - Fill/Finish services With over 50 years of experience, BIOVECTRA delivers custom solutions quickly and efficiently. Let’s connect—schedule a meeting today! https://lnkd.in/eTyq9V6d
BIOVECTRA
Biotechnology
Charlottetown , PE 17,056 followers
A global, full-service CDMO specializing in biologics, small molecules, pDNA/mRNA manufacturing, HPAPIs, & bioreagents.
About us
Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision a reality, is at the heart of our organization. We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for: Biologics Synthetic small molecules Fermented small molecules Highly potent APIs Bioreagents mRNA, pDNA, LNP manufacturing Fill/Finish Flexibility, creativity, and dedication to process optimization are at the heart of our method and process development as well as quality and compliance efforts. We ensure the programs advance on time and with the highest quality outcomes under our project managers’ leadership.
- Website
-
http://www.biovectra.com
External link for BIOVECTRA
- Industry
- Biotechnology
- Company size
- 501-1,000 employees
- Headquarters
- Charlottetown , PE
- Type
- Public Company
- Founded
- 1970
- Specialties
- Speciality Processing Reagents, GMP Custom Chemical Synthesis, mPEG Reagents, Biomass extration and Purification, Cytotoxic Handling Capabilites, DMF Regulations and Filings, APIs, GMP Fermentation, Small Molecule, Biologics, Synthetic Small Molecule, HPAPI, Bioreagents, ADC Manufacturing, Fill/Finish, mRNA Therapeutics, pDNA, and LNP
Locations
-
Primary
Get directions
11 Aviation Avenue
Charlottetown , PE C1e 0A1, CA
Employees at BIOVECTRA
Updates
-
We're excited to be heading to BOS Manchester 2024! Meet with BIOVECTRA to discover how our CDMO expertise can accelerate your development timelines for biologics and synthetic molecules. From microbial fermentation to highly potent APIs and ADC payloads, we deliver scalable solutions tailored to your needs. Schedule a meeting to discuss how we can support your program’s path to market. https://lnkd.in/eVwuNn2n #BOSManchester #BiotechOutsourcing #CDMO #Biologics #SmallMolecule #lipids #ADCs #HPAPIs #microbialfermentation
-
-
It's the final day of the mRNA Health Conference! Don’t miss your chance to connect with the BIOVECTRA team to discuss how our scalable mRNA manufacturing solutions can drive your project forward. Let’s simplify your supply chain, accelerate timelines, and help ensure your program's success. Stop by our booth or schedule a last-minute meeting with us today! #mRNA #HealthConference2024 #Biomanufacturing #CDMO #mRNAmanufacturing #Biotech #Pharma #LifeSciences
-
-
We're on-site in Boston at the 12th International mRNA Health Conference! Come find Jessica, Gbemisola, and the rest of the BIOVECTRA team to learn more about how we can support your mRNA manufacturing needs with scalable solutions. Let's simplify your supply chain, expedite your timelines, and help your project succeed. Schedule a meeting with us today or find us on the show floor! https://lnkd.in/e75s-FAz #mRNA #HealthConference2024 #Biomanufacturing #CDMO #mRNAmanufacturing #Biotech #Pharma #LifeSciences
-
-
Excited to attend BOS Manchester 2024? BIOVECTRA's Wolfgang Schiek will be there and is eager to connect on your complex outsourcing needs for biologics and small molecules. Schedule a meeting with us to discuss how we can streamline your program’s path to market. https://lnkd.in/eVwuNn2n #BOSManchester #BiotechOutsourcing #CDMO #Biologics #SmallMolecule
-
-
We’re excited to connect at next week's International mRNA Health Conference in Boston! Meet our team to discuss how BIOVECTRA’s state-of-the-art Biomanufacturing and Vaccine Center can support your mRNA manufacturing needs with scalable solutions from pDNA and mRNA production to LNP formulations and fill/finish. Find us on the exhibit hall floor to talk about simplifying supply chains, expediting timelines, and driving your project’s success. Schedule a meeting with us today! https://lnkd.in/e75s-FAz #mRNA #HealthConference2024 #Biomanufacturing #CDMO #mRNAmanufacturing #Biotech #Pharma #LifeSciences
-
-
We're in San Diego for World ADC and can't wait to connect with YOU! As a full-service, global CDMO we specialize in delivering robust, scalable solutions that overcome challenges in ADC production. Find BIOVECTRA's Steven Molinski and Andrew Mitchell at booth 704 and learn how we can accelerate your antibody-drug conjugate pipeline. #WorldADC2024 #ADCTherapeutics #CDMO #Biopharma #BiotechInnovation #AntibodyDrugConjugates #PharmaManufacturing #ADCs
-
-
Our 650 plus employees were delighted for the warm reception to Agilent Technologies last week in both Prince Edward Island and Nova Scotia. Thank you Padraig McDonnell, Simon M., and Brian Carothers for your enthusiasm for us becoming a part of Agilent, and for your shared vision for all that the new possibilities we will be able to achieve together! We appreciate that our founders Dr. Regis and Joan Duffy along with Oliver Technow and Ron Keefe, strong leaders that shaped our trajectory as a company, were also there to celebrate this new era with us.
🎉BIOVECTRA and Agilent had an incredible time in Prince Edward Island and Nova Scotia last week at our celebration to mark the joining of our two companies. Agilent acquired BIOVECTRA, a leading specialized CDMO in Canada, in September. Agilent CEO Padraig McDonnell and leaders Simon May and Brian Carothers spoke about the exciting opportunities presented by our partnership—and the important role of our work in improving health. Together, we will offer more CDMO services to our customers, including sterile fill/finish; add capabilities in rapidly growing modalities like GLP-1; provide a single source for gene-editing technology, and much more. All this complements Agilent’s therapeutic oligonucleotide CDMO in Colorado, where we’ve been advancing our customers’ clinical and commercial programs for more than 20 years. We also were honored to be joined by Dr. Regis Duffy, a visionary life science innovator and leader who founded BIOVECTRA more than 50 years ago. We thank the hundreds of BIOVECTRA employees who attended the celebration for their warm welcome and hospitality—and for their passion for our shared mission. And we extend our deep gratitude to former BIOVECTRA CEO Oliver Technow for his leadership and support. Here’s to helping our customers bring great science to life, together. 🎉 Learn more: FAQs for customers: https://bit.ly/3XOz9er About Agilent’s oligonucleotide cGMP manufacturing: https://bit.ly/3YRWvR5 About BIOVECTRA: https://www.biovectra.com/ Highlights for investors: https://bit.ly/3CbI2GN
-
Join BIOVECTRA during World ADC San Diego 2024 to discover how our cutting-edge CDMO services can accelerate your antibody-drug conjugate pipeline. From clinical development to large-scale manufacturing, we specialize in delivering robust, scalable solutions that overcome challenges in ADC production. Schedule a meeting in advance or stop by booth 704 to explore how we can support your program’s success and help bring innovative therapies to market faster. https://lnkd.in/g6ziqPk3 #WorldADC2024 #ADCTherapeutics #CDMO #Biopharma #BiotechInnovation #AntibodyDrugConjugates #PharmaManufacturing #ADCs
-
-
There's just one day left at CPHI Milan but there's still time to connect with BIOVECTRA's Wolfgang and the rest of the group. We'd love to learn more about your upcoming biologics, mRNA, pDNA, and complex chemistry projects. Our unique systems are designed to deliver custom solutions quickly and efficiently! Come find us at stand 5B97!